1&1 FY25 Profit Down, Revenues Rise; Sees EBITDA Growth In FY26, Ahead

Latest Headlines Top Stories Breaking News Stock Alerts Wallstreet Events Industry News Industry News Corp. Calendars Stock Splits Conference Calls Earnings Calendar Earnings Calendar Pos Pre-announcements Profit Warnings Positive Surprise Negative Surprise Latest Earnings FDA Calendars Drug Approvals Clinical Trial Calendar Ratings Changes Cov Initiations Cov. Reiterated Economic News Economic Calendar Economic Scorecard Cryptocurrency Cryptocurrency Morning Mkt Analysis US Commentary European Commentary Asian Commentary Canadian Commentary Indian Commentary Commodities White House General News FX Top Stories Currency Analysis Currency Alerts Economic Calendar Economic Scorecard Coronavirus COVID-19 Calendar Diet & Fitness Kids Health Men's Health Women's Health Cancer News Drug Development Mental Health Slide Shows Entertainment Entertainment Top Stories Classic Rock Rap/Hip-Hop Alternative Content Licensing Content Licensing Newswires & Feeds Content Syndication Digital Signage Services Radio News Services Premium Services Intelligent Investor Biotech Investor NEW Latest News Videos Free Content Press Releases Latest Headlines Stock Alerts Top Stories Breaking News Wallstreet Events Industry News Corp. Calendars Stock Splits Conference Calls Earnings Calendar Earnings Calendar Pos Pre-announcements Profit Warnings Positive Surprise Negative Surprise Latest Earnings FDA Calendars Drug Approvals Clinical Trial Calendar Ratings Changes Cov Initiations Cov. Reiterated Economic Calendar Economic Scorecard Cryptocurrency Market News Morning Mkt Analysis US Commentary European Commentary Asian Commentary Canadian Commentary Indian Commentary Commodities White House General News FX Top Stories Currency Analysis Currency Alerts Economic Calendar Economic Scorecard Health News Coronavirus COVID-19 Calendar Diet & Fitness Kids Health Men's Health Women's Health Cancer News Drug Development Mental Health Slide Shows Entertainment Entertainment News Top Stories Classic Rock Rap/Hip-Hop Alternative Content Licensing Newswires & Feeds Content Syndication Digital Signage Services Radio News Services Intelligent Investor Biotech Investor Latest News Videos Free Content Press Releases Earnings News 1&1 FY25 Profit Down, Revenues Rise; Sees EBITDA Growth In FY26, Ahead By RTT

News Staff Writer ✉ | Published: 3/19/2026 3:11 AM ET

Addas your preferred news source on Google German Telecommunications provider 1&1 AG (1U1.

DE) reported Thursday lower earnings for fiscal year 2025, despite growth in revenues. The company, which is part of United Internet AG (UTDI.

DE), also issued outlook, expecting EBITDA growth until fiscal 2028.

In fiscal 2025, the company's earnings per share decreased 22.3 percent to 0.94 euros compared to 1.21 euros in the previous year. EBIT declined 32.7 percent to 208.2 million euros from 309.4 million euros in the prior year. EBITDA decreased 9 percent to 537.5 million euros from 590.8 million euros last year.

However, revenue increased 1.8 percent to 4.14 billion euros from 4.06 billion euros a year ago, with service revenue up 1.0 percent to 3.34 billion euros. Further, the Management Board and Supervisory Board will propose an unchanged dividend of 0.05 euros per share for fiscal 2025 at the Annual Shareholders' Meeting on May 20. Looking ahead, 1&1 AG expects service revenue for fiscal year 2026 to be at the previous year's level of 3.66 billion euros including 1&1 Versatel.

EBITDA in 2026 is expected to rise to approximately 800 million euros from 689 million euros in 2025 including 1&1 Versatel. For fiscal years 2027 and 2028, the company anticipates operating EBITDA growth of approximately 100 million euros per year, with cash capex expected to remain at a similar level to 2026. For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com Business News Slide Shows Biotech Stocks Facing FDA Decision In March 2026 Biotech Stocks Facing FDA Decision In February 2026 Biotech Stocks Facing FDA Decision In January 2026 Latest Updates on Middle East War Canadian Stocks Tumble As Slump By Gold Prices Weighs March 18, 2026 16:30 ET Crude Oil Edges Lower As Investors Assess Easing Supply Concerns March 18, 2026 14:43 ET Crude Oil Price Climb Weighs On Market Mood March 18, 2026 09:45 ET US

Counter-terrorism Chief Joe Kent Quits Over Middle East War March 18, 2026 05:36 ET NZ

Dollar Rises After Upbeat China Data March 16, 2026 01:27 ET Biotechnology Weekly Update - March 18, 2026 March 18, 2026 11:21 ET BrainsWay’s strong financial performance pushed its stock to a new high, while Maze continues to gain momentum ahead of an important clinical trial readout.

Meanwhile, GSK secured the FDA reapproval of one of its drugs and expanded the label of its RSV vaccine to reach more at-risk adults. These are some of the key stories we are covering in this video. View More Videos RELATED NEWS 1&1 FY25 Profit Down, Revenues Rise; Sees EBITDA Growth In FY26, Ahead Latest Updates on COVID-19 Coast Guard Reinstates 56 Members Who Were Dismissed For Refusing Covid Vaccine February 25, 2026 05:34 ET Editor's Pick Most Emailed Fed Leaves Interest Rates Unchanged, Highlights 'Uncertain' Impact Of Iran War March 18, 2026 14:14 ET U.S. Factory Orders Inch Up In Line With Estimates In January March 18, 2026 10:23 ET U.S. Producer Prices Climb 0.7% In February, Much More Than Expected March 18, 2026 10:09 ET Bank Of Canada Leaves Interest Rates Unchanged For Third Straight Meeting March 18, 2026 10:00 ET U.S. Pending Home Sales Unexpectedly Rebound In February March 17, 2026 10:04 ET Fraport Stock Gains On FY26 EBITDA, Traffic Growth View, Despite Weak FY25 Profit March 17, 2026 07:08 ET U.S. Homebuilder Confidence Improves Modestly In March March 16, 2026 10:51 ET U.S. Industrial Production Rises 0.2% In February, Slightly More Than Expected March 16, 2026 10:43 ET New York Manufacturing Index Unexpectedly Dips Into Negative Territory In March March 16, 2026 10:03 ET Dollar Tree Turns To Profit In Q4, Sees Higher Comps In Q1, FY26; Stock Down March 16, 2026 07:14

Et Yit

Oyj Names Erkka Repo New CFO; To Leave Aspo Group CFO Role By Sept 2026 March 17, 2026 03:18 ET Orica Settles Litigation With CF Industries And Expands U.S. Operations March 15, 2026 22:40 ET Dollar Tree Turns To Profit In Q4, Sees Higher Comps In Q1, FY26; Stock Down March 16, 2026 07:14 ET Lilly Reports Topline Results From Phase 3 ADorable-1 Trial March 16, 2026 07:13

Et Pmi

U.S. To Launch Business Solutions Center In Tampa, Florida March 17, 2026 08:17 ET Fraport Stock Gains On FY26 EBITDA, Traffic Growth View, Despite Weak FY25 Profit March 17, 2026 07:08 ET Galaxy Z Fold 8 To Feature Larger Battery Upgrade March 16, 2026 16:12 ET Public Storage To Buy National Storage For $10.5 Bln; NSA Up Over 26% In Pre-Market March 16, 2026 07:56 ET Healthpeak's Janus Living Launches IPO Of 37 Mln Shares March 16, 2026 07:10 ET Crescita Therapeutics To Be Acquired By ClinActiv In All Cash Deal March 16, 2026 07:54 ET Mastercard To Acquire BVNK March 17, 2026 08:21 ET Chipotle Mexican Grill Launches Cilantro Lime Sauce Across U.S. And Canada March 18, 2026 08:41 ET Fertitta Entertainment Reportedly In Talks To Acquire Caesars Entertainment March 15, 2026 03:27 ET Garofalo Health Care S. P.

A Reveals Climb In Full Year Profit March 16, 2026 13:59 ET Telix Resubmits TLX101-Px NDA To FDA For Brain Cancer Imaging Agent March 15, 2026 20:59 ET StarragTornos Group AG Announces Fall In Full Year Bottom Line March 16, 2026 14:25 ET Orica Settles Litigation With CF Industries And Expands U.S.